Temporary laboratory closure – Metrion still open for discussion of future business
In response to the global COVID-19 outbreak, Metrion Biosciences has decided to close our laboratory operations to help us to safeguard the health and safety of our employees [...]
Metrion’s CEO reflects on participation in Goldman Sachs’ 10,000 Small Businesses UK
During the second half of 2019 Metrion’s CEO Andy Southan spent three months on the Goldman Sachs 10,000 Small Businesses programme. In this blog he reflects on the [...]
Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery
Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special [...]
Nav1.5(Late) Cardiac Safety Assay on QPatch
The Metrion Biosciences team have recently produced a second application note in collaboration with Sophion Bioscience, describing the use of a ∆KPQ LQT3 mutant to create and validate [...]
Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline
Metrion Biosciences’ tenth External Speaker Series presentation featured Dr Catherine Hutchings, a highly experienced biologics drug discovery researcher and independent consultant. Dr Hutchings’ presentation included an overview of [...]
An Interview with Professor Nikita Gamper
Professor Nikita Gamper, the ninth contributor to Metrion Biosciences External Speaker Series, gives a perspective below regarding his ion channel research focus and collaboration activities with scientists from [...]
ELRIG: Advances in Cell Based Screening – Gothenburg, Sweden
ELRIG is a not-for-profit organisation aiming to provide access to high level scientific content, promote innovation in drug discovery and provide networking platforms for the life science community. [...]
Ion Channels in Drug Discovery XIX – Satellite event at BPS 2019
Ion channels continue to rise in prominence in both academic and commercial areas. Metrion Biosciences, alongside Sophion Bioscience, Nanion Technologies, Evotec and SB Drug Discovery sponsored the “Ion [...]